LG Electronics Inc. is aiming at securing new avenues for growth in the functional material industry by launching the production of antibacterial glass powder,
Leveraging its expertise in independent glass formulation, design technology, and understanding of real-life usage scenarios for home electronics, the company has successfully developed an antibacterial glass powder.
Since last year, LG has been incorporating antibacterial glass powder into plastic components, such as handles in refrigerators, washing machines, and air conditioners, to ensure the hygienic usage of these products.
Additionally, LG has made advancements in the development of soluble glass, which effectively releases antibacterial glass material.
LG, which has 219 patents in the glass powder field, operates a production facility with an annual capacity of 4,500 tons.


Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 



